Hippo (HIPO) Financials

$23.02 +0.68 (+3.03%)

Closing price 03:59 PM Eastern

Extended Trading

$23.06 +0.05 (+0.21%)

As of 04:04 PM Eastern

Annual Income Statements for Hippo

This table shows Hippo's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021
Net Income / (Loss) Attributable to Common Shareholders	-41	-273	-333	-371
Consolidated Net Income / (Loss)	-29	-263	-327	-368
Net Income / (Loss) Continuing Operations	-29	-263	-327	-169
Total Pre-Tax Income	-27	-263	-325	-367
Total Operating Income	-82	-263	-328	-215
Total Gross Profit	74	-51	-42	-35
Total Revenue	372	210	120	91
Operating Revenue	372	210	120	91
Total Cost of Revenue	298	261	161	126
Operating Cost of Revenue	298	261	161	126
Total Operating Expenses	156	212	286	180
Selling, General & Admin Expense	71	80	72	49
Marketing Expense	51	80	102	95
Research & Development Expense	31	47	58	36
Restructuring Charge	3.60	5.50	55	0.00
Total Other Income / (Expense), net	54	0.00	0.00	47
Other Income / (Expense), net	54	0.00	0.00	-
Income Tax Expense	1.20	0.50	1.30	0.70
Net Income / (Loss) Attributable to Noncontrolling Interest	12	10	6.90	3.50
Basic Earnings per Share	($1.64)	($11.58)	($14.66)	($34.11)
Weighted Average Basic Shares Outstanding	24.70M	23.58M	22.75M	10.89M
Diluted Earnings per Share	($1.64)	($11.58)	($14.66)	($34.11)
Weighted Average Diluted Shares Outstanding	24.70M	23.58M	22.75M	10.89M
Weighted Average Basic & Diluted Shares Outstanding	25.08M	24.31M	23.31M	566.27M

This table shows Hippo's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	9/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Income / (Loss) Attributable to Common Shareholders	-8.50	-36	-42	-53	-108	-70	-63	-129
Consolidated Net Income / (Loss)	-5.20	-33	-39	-50	-105	-68	-61	-128
Net Income / (Loss) Continuing Operations	-5.20	-33	-39	-50	-105	-68	-61	-128
Total Pre-Tax Income	-5.20	-33	-39	-51	-105	-68	-60	-127
Total Operating Income	-5.20	-33	-40	-51	-105	-68	-61	-127
Total Gross Profit	21	12	9.50	0.90	-48	-14	-3.70	-8.80
Total Revenue	96	85	65	58	48	40	36	31
Operating Revenue	96	85	65	58	48	40	36	31
Total Cost of Revenue	74	73	55	57	96	54	40	40
Operating Cost of Revenue	74	73	55	57	96	54	40	40
Total Operating Expenses	27	45	50	52	57	54	57	119
Selling, General & Admin Expense	15	18	18	21	22	20	18	19
Marketing Expense	13	14	16	19	23	22	28	29
Research & Development Expense	7.00	8.30	10	12	13	12	12	15
Other Operating Expenses / (Income)	-0.10	-	-	0.00	0.00	-	-	-
Restructuring Charge	0.00	3.60	5.50	0.00	0.00	0.00	-	55
Other Special Charges / (Income)	-8.20	-	-	0.00	-	-	-	-
Total Other Income / (Expense), net	0.00	0.00	-	0.00	0.00	0.00	-1.40	0.10
Income Tax Expense	0.00	0.20	0.30	-0.30	0.20	0.30	0.50	0.30
Net Income / (Loss) Attributable to Noncontrolling Interest	3.30	2.60	3.00	2.80	2.60	1.70	2.60	1.70
Basic Earnings per Share	($0.34)	($1.47)	($1.80)	($2.24)	($4.61)	($3.01)	($2.77)	($5.66)
Weighted Average Basic Shares Outstanding	25.07M	24.23M	23.58M	23.73M	23.39M	23.20M	22.75M	22.84M
Diluted Earnings per Share	($0.34)	($1.47)	($1.80)	($2.24)	($4.61)	($3.01)	($2.77)	($5.66)
Weighted Average Diluted Shares Outstanding	25.07M	24.23M	23.58M	23.73M	23.39M	23.20M	22.75M	22.84M
Weighted Average Basic & Diluted Shares Outstanding	24.36M	24.43M	24.31M	23.89M	23.67M	23.26M	23.31M	23.06M

This table details how cash moves in and out of Hippo's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021
Net Change in Cash & Equivalents	38	-49	-574	326
Net Cash From Operating Activities	48	-92	-162	-125
Net Cash From Continuing Operating Activities	48	-92	-162	-125
Net Income / (Loss) Continuing Operations	-29	-263	-327	-368
Consolidated Net Income / (Loss)	-29	-263	-327	-368
Depreciation Expense	23	20	15	11
Non-Cash Adjustments To Reconcile Net Income	99	188	180	241
Changes in Operating Assets and Liabilities, net	-46	-37	-30	-29
Net Cash From Investing Activities	30	58	-406	-30
Net Cash From Continuing Investing Activities	30	58	-406	-30
Purchase of Property, Plant & Equipment	-12	-47	-20	-14
Purchase of Investments	-368	-410	-793	-26
Divestitures	73	0.00	0.00	-
Sale and/or Maturity of Investments	337	517	409	17
Other Investing Activities, net	0.20	-3.20	-2.00	-2.90
Net Cash From Financing Activities	-40	-15	-6.80	481
Net Cash From Continuing Financing Activities	-40	-15	-6.80	481
Repurchase of Common Equity	-16	-1.80	0.00	-
Payment of Dividends	-20	-9.60	-5.30	-
Issuance of Common Equity	6.70	2.80	4.10	-
Other Financing Activities, net	-11	-6.00	-5.60	482

This table details how cash moves in and out of Hippo's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Change in Cash & Equivalents	-43	68	-74	31	18	-24	-148	68
Net Cash From Operating Activities	-11	18	-49	1.10	-9.30	-36	-30	-43
Net Cash From Continuing Operating Activities	-11	18	-49	1.10	-9.30	-36	-30	-43
Net Income / (Loss) Continuing Operations	-37	-33	-39	-50	-105	-68	-61	-128
Consolidated Net Income / (Loss)	-37	-33	-39	-50	-105	-68	-61	-128
Depreciation Expense	5.90	5.60	5.40	4.90	5.20	4.30	4.00	3.80
Non-Cash Adjustments To Reconcile Net Income	33	59	-8.80	50	99	48	57	88
Changes in Operating Assets and Liabilities, net	-12	-14	-5.80	-3.80	-7.90	-20	-31	-7.50
Net Cash From Investing Activities	-28	59	-22	31	35	14	-115	113
Net Cash From Continuing Investing Activities	-28	59	-22	31	35	14	-115	113
Purchase of Property, Plant & Equipment	-3.80	-3.40	-4.50	-4.70	-34	-3.90	-3.50	-5.50
Purchase of Investments	-84	-55	-119	-84	-96	-111	-148	-237
Sale and/or Maturity of Investments	60	117	104	119	165	130	36	355
Net Cash From Financing Activities	-4.40	-8.00	-3.80	-0.90	-8.00	-1.90	-3.10	-1.10
Net Cash From Continuing Financing Activities	-4.40	-8.00	-3.70	-1.00	-8.00	-1.90	-3.10	-1.10
Payment of Dividends	-2.70	-7.60	-3.10	-0.10	-5.80	-0.60	-3.10	-
Issuance of Common Equity	1.20	1.00	0.40	0.50	1.70	0.20	0.70	0.10
Other Financing Activities, net	-2.90	-1.40	-1.00	-1.40	-2.30	-1.30	-1.70	-1.20

This table presents Hippo's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021
Total Assets	1,543	1,525	1,569	1,643
Total Current Assets	365	287	627	841
Cash & Equivalents	198	142	195	776
Accounts Receivable	167	145	107	57
Plant, Property, & Equipment, net	206	162	0.00	0.00
Plant, Property & Equipment, gross	206	162	-	-
Total Noncurrent Assets	973	1,076	942	802
Long-Term Investments	168	187	121	55
Intangible Assets	65	76	66	58
Other Noncurrent Operating Assets	740	813	756	635
Total Liabilities & Shareholders' Equity	1,543	1,525	1,569	1,643
Total Liabilities	1,178	1,140	975	781
Total Current Liabilities	686	696	629	516
Accrued Expenses	87	114	128	95
Other Current Liabilities	599	583	501	420
Total Noncurrent Liabilities	492	444	346	265
Other Noncurrent Operating Liabilities	492	444	346	265
Commitments & Contingencies	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	365	385	594	862
Total Preferred & Common Equity	362	378	590	860
Total Common Equity	362	378	590	860
Common Stock	1,640	1,615	1,558	1,488
Retained Earnings	-1,275	-1,234	-961	-628
Accumulated Other Comprehensive Income / (Loss)	-2.70	-2.90	-7.00	-0.70
Noncontrolling Interest	3.10	6.80	3.60	2.10

This table presents Hippo's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022
Period end date	9/30/2024	3/31/2024	9/30/2023	6/30/2023	3/31/2023	9/30/2022
Total Assets	1,545	1,496	1,647	1,681	1,605	1,630
Total Current Assets	743	502	562	577	613	658
Cash & Equivalents	191	223	228	200	189	347
Restricted Cash	40	-	-	-	-	-
Short-Term Investments	354	125	189	229	290	222
Accounts Receivable	158	154	145	148	134	90
Plant, Property, & Equipment, net	0.00	0.00	0.00	0.00	0.00	0.00
Total Noncurrent Assets	802	994	1,085	1,104	992	972
Intangible Assets	74	75	71	69	67	65
Other Noncurrent Operating Assets	728	757	873	899	784	798
Total Liabilities & Shareholders' Equity	1,545	1,496	1,647	1,681	1,605	1,630
Total Liabilities	1,215	1,142	1,236	1,234	1,062	991
Total Current Liabilities	710	705	776	798	687	661
Accrued Expenses	98	105	125	128	133	124
Other Current Liabilities	612	600	651	670	555	537
Total Noncurrent Liabilities	505	436	460	436	374	330
Other Noncurrent Operating Liabilities	505	436	460	436	374	330
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	330	355	411	447	543	639
Total Preferred & Common Equity	326	351	407	446	538	635
Total Common Equity	326	351	407	446	538	635
Common Stock	1,645	1,625	1,606	1,591	1,575	1,541
Retained Earnings	-1,319	-1,270	-1,192	-1,139	-1,031	-898
Accumulated Other Comprehensive Income / (Loss)	0.50	-3.40	-7.10	-6.40	-5.30	-7.80
Noncontrolling Interest	3.70	3.60	4.30	1.40	4.70	4.00

This table displays calculated financial ratios and metrics derived from Hippo's official financial filings.

Metric	2024	2023	2022	2021
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021
Growth Metrics	-	-	-	-
Revenue Growth	77.44%	75.19%	31.25%	76.74%
EBITDA Growth	98.23%	22.08%	-69.93%	39.76%
EBIT Growth	89.56%	19.65%	-52.21%	30.99%
NOPAT Growth	68.89%	19.65%	-52.21%	-83.70%
Net Income Growth	89.13%	19.45%	11.25%	-160.18%
EPS Growth	85.84%	21.01%	57.02%	-160.18%
Operating Cash Flow Growth	151.41%	42.79%	-29.72%	-90.37%
Free Cash Flow Firm Growth	99.36%	-78.76%	38.97%	0.00%
Invested Capital Growth	-100.00%	218.34%	-312.22%	124.56%
Revenue Q/Q Growth	0.00%	15.86%	3.28%	0.00%
EBITDA Q/Q Growth	0.00%	8.39%	1.11%	0.00%
EBIT Q/Q Growth	0.00%	7.35%	0.85%	0.00%
NOPAT Q/Q Growth	0.00%	7.35%	0.85%	0.00%
Net Income Q/Q Growth	0.00%	7.43%	-0.34%	0.00%
EPS Q/Q Growth	0.00%	6.46%	-1.10%	0.00%
Operating Cash Flow Q/Q Growth	0.00%	-24.86%	-18.14%	16.05%
Free Cash Flow Firm Q/Q Growth	0.00%	-218.07%	0.00%	0.00%
Invested Capital Q/Q Growth	0.00%	137.73%	-22.45%	0.00%
Profitability Metrics	-	-	-	-
Gross Margin	19.97%	-24.37%	-34.75%	-38.27%
EBITDA Margin	-1.16%	-116.12%	-261.07%	-201.64%
Operating Margin	-22.01%	-125.56%	-273.77%	-236.07%
EBIT Margin	-7.39%	-125.56%	-273.77%	-236.07%
Profit (Net Income) Margin	-7.69%	-125.42%	-272.77%	-403.40%
Tax Burden Percent	104.38%	100.19%	100.40%	100.19%
Interest Burden Percent	99.64%	99.70%	99.24%	170.55%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	-206.59%	-4,286.28%	0.00%	0.00%
ROIC Less NNEP Spread (ROIC-NNEP)	-214.87%	-4,270.05%	0.00%	0.00%
Return on Net Nonoperating Assets (RNNOA)	198.97%	4,232.51%	0.00%	0.00%
Return on Equity (ROE)	-7.63%	-53.77%	-44.87%	-73.07%
Cash Return on Invested Capital (CROIC)	-6.59%	-516.59%	0.00%	-1,189.19%
Operating Return on Assets (OROA)	-1.79%	-17.02%	-20.41%	-16.42%
Return on Assets (ROA)	-1.86%	-17.00%	-20.33%	-28.06%
Return on Common Equity (ROCE)	-7.53%	-53.20%	-44.70%	-47.89%
Return on Equity Simple (ROE_SIMPLE)	-7.90%	-69.60%	-55.35%	-42.80%
Net Operating Profit after Tax (NOPAT)	-57	-184	-229	-151
NOPAT Margin	-15.41%	-87.89%	-191.64%	-165.25%
Net Nonoperating Expense Percent (NNEP)	8.27%	-16.23%	-13.12%	-40.41%
Return On Investment Capital (ROIC_SIMPLE)	-15.70%	-47.91%	-38.65%	-
Cost of Revenue to Revenue	80.03%	124.37%	134.75%	138.27%
SG&A Expenses to Revenue	19.00%	37.96%	59.73%	53.95%
R&D to Revenue	8.25%	22.41%	48.04%	39.69%
Operating Expenses to Revenue	41.98%	101.19%	239.01%	197.81%
Earnings before Interest and Taxes (EBIT)	-28	-263	-328	-215
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-4.30	-244	-313	-184
Valuation Ratios	-	-	-	-
Price to Book Value (P/BV)	1.80	0.58	0.53	1.85
Price to Tangible Book Value (P/TBV)	2.20	0.72	0.60	2.13
Price to Revenue (P/Rev)	1.75	1.04	2.62	17.46
Price to Earnings (P/E)	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	0.00	0.00	0.00	34.16
Enterprise Value to Revenue (EV/Rev)	0.78	0.00	0.00	8.28
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	6.11	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-
Debt to Equity	0.00	0.00	0.00	0.00
Long-Term Debt to Equity	0.00	0.00	0.00	0.00
Financial Leverage	-0.93	-0.99	-1.02	-1.07
Leverage Ratio	4.09	3.16	2.21	2.60
Compound Leverage Factor	4.08	3.15	2.19	4.44
Debt to Total Capital	0.00%	0.00%	0.00%	0.00%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.85%	1.77%	0.61%	0.24%
Common Equity to Total Capital	99.15%	98.23%	99.39%	99.76%
Debt to EBITDA	0.00	0.00	0.00	0.00
Net Debt to EBITDA	0.00	0.00	0.00	0.00
Long-Term Debt to EBITDA	0.00	0.00	0.00	0.00
Debt to NOPAT	0.00	0.00	0.00	0.00
Net Debt to NOPAT	0.00	0.00	0.00	0.00
Long-Term Debt to NOPAT	0.00	0.00	0.00	0.00
Altman Z-Score	-0.89	-1.77	-1.28	0.55
Noncontrolling Interest Sharing Ratio	1.32%	1.06%	0.39%	34.46%
Liquidity Ratios	-	-	-	-
Current Ratio	0.53	0.41	1.00	1.63
Quick Ratio	0.53	0.41	1.00	1.63
Cash Flow Metrics	-	-	-	-
Free Cash Flow to Firm (FCFF)	-1.83	-287	-160	-263
Operating Cash Flow to CapEx	395.83%	-197.86%	-819.80%	-882.98%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-
Asset Turnover	0.24	0.14	0.07	0.07
Accounts Receivable Turnover	2.38	1.66	1.46	1.95
Inventory Turnover	0.00	0.00	0.00	0.00
Fixed Asset Turnover	2.03	0.00	0.00	0.00
Accounts Payable Turnover	0.00	0.00	0.00	0.00
Days Sales Outstanding (DSO)	153.12	219.66	249.58	187.30
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	0.00	0.00	0.00	0.00
Cash Conversion Cycle (CCC)	153.12	219.66	249.58	187.30
Capital & Investment Metrics	-	-	-	-
Invested Capital	0.00	56	-47	22
Invested Capital Turnover	13.41	48.77	-9.65	-2.69
Increase / (Decrease) in Invested Capital	-56	102	-69	112
Enterprise Value (EV)	290	-105	-323	755
Market Capitalization	652	218	314	1,592
Book Value per Share	$14.86	$15.82	$25.58	$1.53
Tangible Book Value per Share	$12.19	$12.65	$22.73	$1.33
Total Capital	365	385	594	862
Total Debt	0.00	0.00	0.00	0.00
Total Long-Term Debt	0.00	0.00	0.00	0.00
Net Debt	-365	-329	-640	-840
Capital Expenditures (CapEx)	12	47	20	14
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-519	-551	-522	-459
Debt-free Net Working Capital (DFNWC)	-321	-409	-2.60	326
Net Working Capital (NWC)	-321	-409	-2.60	326
Net Nonoperating Expense (NNE)	-29	79	97	217
Net Nonoperating Obligations (NNO)	-365	-329	-640	-840
Total Depreciation and Amortization (D&A)	23	20	15	31
Debt-free, Cash-free Net Working Capital to Revenue	-139.48%	-262.71%	-436.01%	-503.40%
Debt-free Net Working Capital to Revenue	-86.37%	-194.95%	-2.17%	357.02%
Net Working Capital to Revenue	-86.37%	-194.95%	-2.17%	357.02%
Earnings Adjustments	-	-	-	-
Adjusted Basic Earnings per Share	($1.64)	($11.58)	($14.66)	($34.00)
Adjusted Weighted Average Basic Shares Outstanding	24.70M	23.58M	22.75M	10.89M
Adjusted Diluted Earnings per Share	($1.64)	($11.58)	($14.66)	($34.00)
Adjusted Weighted Average Diluted Shares Outstanding	24.70M	23.58M	22.75M	10.89M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	25.08M	24.31M	23.31M	22.65M
Normalized Net Operating Profit after Tax (NOPAT)	-55	-180	-191	-151
Normalized NOPAT Margin	-14.73%	-86.06%	-159.30%	-165.25%
Pre Tax Income Margin	-7.36%	-125.18%	-271.68%	-402.63%
Debt Service Ratios	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-
Dividend Payout Ratio	-71.33%	-3.65%	-1.62%	0.00%
Augmented Payout Ratio	-125.87%	-4.33%	-1.62%	0.00%

This table displays calculated financial ratios and metrics derived from Hippo's official financial filings.

Metric	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	9/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Growth Metrics	-	-	-	-	-	-	-	-
Revenue Growth	100.21%	113.82%	80.17%	87.95%	66.20%	62.45%	11.88%	44.13%
EBITDA Growth	100.70%	56.80%	40.51%	62.97%	-46.33%	-1.28%	3.47%	-418.49%
EBIT Growth	95.05%	51.26%	35.68%	60.22%	-46.44%	-1.81%	2.19%	-326.85%
NOPAT Growth	95.05%	51.26%	34.21%	60.25%	-45.83%	-0.30%	4.38%	-126.51%
Net Income Growth	95.06%	51.40%	34.88%	60.55%	-46.11%	-2.41%	-1.85%	-326.42%
EPS Growth	92.62%	51.16%	35.02%	60.42%	-41.85%	0.00%	50.36%	-326.42%
Operating Cash Flow Growth	-13.98%	149.58%	-61.13%	102.56%	68.79%	39.08%	-467.92%	14.00%
Free Cash Flow Firm Growth	110.14%	-16.35%	-597.67%	3,250.68%	-52.69%	-46.14%	0.00%	102.37%
Invested Capital Growth	-116.92%	-101.81%	218.34%	-284.07%	-700.00%	-311.78%	-312.22%	-172.26%
Revenue Q/Q Growth	12.22%	31.94%	11.79%	20.96%	19.85%	11.17%	16.61%	6.97%
EBITDA Q/Q Growth	102.56%	21.55%	23.85%	54.21%	-57.91%	-10.68%	52.59%	-80.94%
EBIT Q/Q Growth	84.19%	18.16%	20.55%	51.81%	-55.56%	-10.47%	50.86%	-77.41%
NOPAT Q/Q Growth	84.19%	18.16%	20.55%	51.81%	-55.56%	-10.47%	52.00%	-76.81%
Net Income Q/Q Growth	84.29%	15.99%	21.67%	52.19%	-54.48%	-12.56%	52.55%	-77.08%
EPS Q/Q Growth	76.87%	18.33%	19.64%	51.41%	-53.16%	-8.66%	51.06%	-77.08%
Operating Cash Flow Q/Q Growth	-159.89%	136.49%	-4,509.09%	111.83%	73.95%	-18.60%	30.00%	-44.30%
Free Cash Flow Firm Q/Q Growth	140.45%	-33.85%	-277.90%	15.20%	-4.28%	153.72%	1,097.72%	-98.37%
Invested Capital Q/Q Growth	-63.53%	2.01%	137.73%	-25.09%	-52.13%	-64.82%	-22.45%	-295.41%
Profitability Metrics	-	-	-	-	-	-	-	-
Gross Margin	22.30%	13.75%	14.73%	1.56%	-100.21%	-34.42%	-10.34%	-28.66%
EBITDA Margin	0.73%	-32.08%	-53.95%	-79.20%	-209.22%	-158.79%	-163.41%	-401.95%
Operating Margin	-5.45%	-38.66%	-62.33%	-87.70%	-220.13%	-169.60%	-170.67%	-414.66%
EBIT Margin	-5.45%	-38.66%	-62.33%	-87.70%	-220.13%	-169.60%	-174.58%	-414.33%
Profit (Net Income) Margin	-5.45%	-38.90%	-61.09%	-87.18%	-220.55%	-171.11%	-168.99%	-415.31%
Tax Burden Percent	100.00%	100.61%	100.77%	99.41%	100.19%	100.44%	100.83%	100.24%
Interest Burden Percent	100.00%	100.00%	97.26%	100.00%	100.00%	100.44%	96.00%	100.00%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	0.00%	0.00%	-2,127.62%	0.00%	0.00%	0.00%	0.00%	-4,577.03%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	0.00%	-2,125.30%	0.00%	0.00%	0.00%	0.00%	-4,572.01%
Return on Net Nonoperating Assets (RNNOA)	0.00%	0.00%	2,106.61%	0.00%	0.00%	0.00%	0.00%	4,528.44%
Return on Equity (ROE)	-32.94%	-50.79%	-21.01%	-54.10%	-60.30%	-48.55%	-44.87%	-48.59%
Cash Return on Invested Capital (CROIC)	0.00%	0.00%	-516.59%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Return on Assets (OROA)	-1.02%	-6.36%	-8.45%	-9.69%	-20.48%	-13.96%	-13.01%	-29.21%
Return on Assets (ROA)	-1.02%	-6.40%	-8.28%	-9.63%	-20.52%	-14.09%	-12.60%	-29.28%
Return on Common Equity (ROCE)	-32.73%	-50.32%	-20.78%	-53.67%	-60.11%	-48.26%	-44.70%	-48.39%
Return on Equity Simple (ROE_SIMPLE)	-39.22%	-64.92%	0.00%	-69.80%	-81.08%	-60.95%	0.00%	-51.24%
Net Operating Profit after Tax (NOPAT)	-3.64	-23	-28	-35	-74	-47	-43	-89
NOPAT Margin	-3.81%	-27.06%	-43.63%	-61.39%	-154.09%	-118.72%	-119.47%	-290.26%
Net Nonoperating Expense Percent (NNEP)	-0.27%	-1.78%	-2.32%	-2.41%	-4.89%	-2.99%	-2.40%	-5.02%
Cost of Revenue to Revenue	77.70%	86.25%	85.27%	98.44%	200.21%	134.42%	110.34%	128.66%
SG&A Expenses to Revenue	16.02%	21.50%	27.29%	35.88%	45.07%	49.75%	49.72%	61.89%
R&D to Revenue	7.33%	9.75%	16.12%	20.62%	27.46%	29.15%	32.12%	48.21%
Operating Expenses to Revenue	27.75%	52.41%	77.05%	89.25%	119.92%	135.18%	160.34%	385.99%
Earnings before Interest and Taxes (EBIT)	-5.20	-33	-40	-51	-105	-68	-63	-127
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	0.70	-27	-35	-46	-100	-63	-59	-123
Valuation Ratios	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.29	1.26	0.58	0.46	0.86	0.70	0.53	0.67
Price to Tangible Book Value (P/TBV)	1.67	1.61	0.72	0.56	1.02	0.80	0.60	0.74
Price to Revenue (P/Rev)	1.39	1.74	1.04	1.04	2.50	2.80	2.62	3.66
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Revenue (EV/Rev)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Financial Leverage	-1.48	-1.26	-0.99	-1.18	-1.08	-1.03	-1.02	-0.99
Leverage Ratio	4.15	3.45	3.16	3.12	2.76	2.43	2.21	2.13
Compound Leverage Factor	4.15	3.45	3.08	3.12	2.76	2.44	2.12	2.13
Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	1.12%	1.01%	1.77%	1.05%	0.31%	0.87%	0.61%	0.63%
Common Equity to Total Capital	98.88%	98.99%	98.23%	98.95%	99.69%	99.13%	99.39%	99.37%
Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Altman Z-Score	-0.78	-1.02	-1.29	-1.07	-1.03	-0.80	-0.72	-0.70
Noncontrolling Interest Sharing Ratio	0.66%	0.92%	1.06%	0.79%	0.31%	0.58%	0.39%	0.41%
Liquidity Ratios	-	-	-	-	-	-	-	-
Current Ratio	1.05	0.71	0.41	0.72	0.72	0.89	1.00	1.00
Quick Ratio	0.99	0.71	0.41	0.72	0.72	0.89	1.00	1.00
Cash Flow Metrics	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	134	56	-131	73	64	67	26	2.19
Operating Cash Flow to CapEx	-278.95%	520.59%	-1,077.78%	23.40%	-27.68%	-915.38%	-860.00%	-781.82%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-
Asset Turnover	0.19	0.16	0.14	0.11	0.09	0.08	0.07	0.07
Accounts Receivable Turnover	1.98	1.77	1.66	1.54	1.43	1.39	1.46	1.54
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Accounts Payable Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Sales Outstanding (DSO)	184.43	205.69	219.66	237.15	254.55	263.07	249.58	236.35
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Cash Conversion Cycle (CCC)	184.43	205.69	219.66	237.15	254.55	263.07	249.58	236.35
Capital & Investment Metrics	-	-	-	-	-	-	-	-
Invested Capital	-255	-156	56	-147	-118	-77	-47	-38
Invested Capital Turnover	-1.62	-2.19	48.77	-1.95	-3.14	-6.62	-9.65	15.77
Increase / (Decrease) in Invested Capital	-138	-79	102	-109	-137	-114	-69	-91
Enterprise Value (EV)	-161	-63	-105	-365	-179	-237	-323	-249
Market Capitalization	421	444	218	189	385	378	314	424
Book Value per Share	$13.10	$14.45	$15.82	$17.20	$19.15	$23.10	$25.58	$1.11
Tangible Book Value per Share	$10.13	$11.36	$12.65	$14.22	$16.20	$20.22	$22.73	$1.00
Total Capital	330	355	385	411	447	543	594	639
Total Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Long-Term Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt	-585	-511	-329	-558	-565	-620	-640	-677
Capital Expenditures (CapEx)	3.80	3.40	4.50	4.70	34	3.90	3.50	5.50
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-553	-551	-551	-631	-650	-554	-522	-571
Debt-free Net Working Capital (DFNWC)	33	-203	-409	-214	-221	-74	-2.60	-3.20
Net Working Capital (NWC)	33	-203	-409	-214	-221	-74	-2.60	-3.20
Net Nonoperating Expense (NNE)	1.56	10	11	15	32	21	18	38
Net Nonoperating Obligations (NNO)	-585	-511	-329	-558	-565	-620	-640	-677
Total Depreciation and Amortization (D&A)	5.90	5.60	5.40	4.90	5.20	4.30	4.00	3.80
Debt-free, Cash-free Net Working Capital to Revenue	-182.50%	-216.24%	-262.71%	-348.34%	-421.95%	-410.15%	-436.01%	-492.92%
Debt-free Net Working Capital to Revenue	10.77%	-79.73%	-194.95%	-118.01%	-143.38%	-55.11%	-2.17%	-2.76%
Net Working Capital to Revenue	10.77%	-79.73%	-194.95%	-118.01%	-143.38%	-55.11%	-2.17%	-2.76%
Earnings Adjustments	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.34)	($1.47)	($1.80)	($2.24)	($4.61)	($3.01)	($2.77)	($5.66)
Adjusted Weighted Average Basic Shares Outstanding	25.07M	24.23M	23.58M	23.73M	23.39M	23.20M	22.75M	22.84M
Adjusted Diluted Earnings per Share	($0.34)	($1.47)	($1.80)	($2.24)	($4.61)	($3.01)	($2.77)	($5.66)
Adjusted Weighted Average Diluted Shares Outstanding	25.07M	24.23M	23.58M	23.73M	23.39M	23.20M	22.75M	22.84M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	($1.80)	$0.00	$0.00	$0.00	($2.77)	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	24.36M	24.43M	24.31M	23.89M	23.67M	23.26M	23.31M	23.06M
Normalized Net Operating Profit after Tax (NOPAT)	-9.38	-21	-24	-35	-74	-47	-43	-50
Normalized NOPAT Margin	-9.82%	-24.10%	-37.66%	-61.39%	-154.09%	-118.72%	-119.47%	-164.17%
Pre Tax Income Margin	-5.45%	-38.66%	-60.62%	-87.70%	-220.13%	-170.35%	-167.60%	-414.33%
Debt Service Ratios	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-
Dividend Payout Ratio	-10.55%	-7.28%	-3.65%	-3.38%	-2.63%	0.00%	-1.62%	0.00%
Augmented Payout Ratio	-10.55%	-7.98%	-4.33%	-4.01%	-3.13%	-0.06%	-1.62%	0.00%

Frequently Asked Questions About Hippo's Financials

When does Hippo's fiscal year end?

According to the most recent income statement we have on file, Hippo's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Hippo's net income changed over the last 3 years?

Hippo's net income appears to be on a downward trend, with a most recent value of -$28.60 million in 2024, falling from -$367.90 million in 2021. The previous period was -$263 million in 2023. View Hippo's forecast to see where analysts expect Hippo to go next.

What is Hippo's operating income?

Hippo's total operating income in 2024 was -$81.90 million, based on the following breakdown:

Total Gross Profit: $74.30 million
Total Operating Expenses: $156.20 million

How has Hippo revenue changed over the last 3 years?

Over the last 3 years, Hippo's total revenue changed from $91.20 million in 2021 to $372.10 million in 2024, a change of 308.0%.

How much debt does Hippo have?

Hippo's total liabilities were at $1.18 billion at the end of 2024, a 3.4% increase from 2023, and a 50.9% increase since 2021.

How much cash does Hippo have?

In the past 3 years, Hippo's cash and equivalents has ranged from $142.10 million in 2023 to $775.60 million in 2021, and is currently $197.60 million as of their latest financial filing in 2024.

How has Hippo's book value per share changed over the last 3 years?

Over the last 3 years, Hippo's book value per share changed from 1.53 in 2021 to 14.86 in 2024, a change of 873.0%.

Related Companies

This page (NYSE:HIPO) was last updated on 5/27/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Hippo (HIPO) Financials

Frequently Asked Questions About Hippo's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Hippo (HIPO) Financials

Annual Income Statements for Hippo

Quarterly Income Statements for Hippo

Annual Cash Flow Statements for Hippo

Quarterly Cash Flow Statements for Hippo

Annual Balance Sheets for Hippo

Quarterly Balance Sheets for Hippo

Annual Metrics And Ratios for Hippo

Quarterly Metrics And Ratios for Hippo

Frequently Asked Questions About Hippo's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools